Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
PLATINUM RESISTANT CANCER
.
Show all posts
Showing posts with label
PLATINUM RESISTANT CANCER
.
Show all posts
Friday, July 3, 2026
FDA Approves Lifyorli (relacorilant) Plus Nab-Paclitaxel for the Treatment of Patients with Platinum-Resistant Ovarian Cancer
›
In continuation of my update on relacorilant Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the di...
›
Home
View web version
